799-7596909-1/10002/1

AbbVie Deutschland GmbH & Co. KG — FEI 3002807401

Refusal Details

Date
January 30, 2026
Country
Germany
Product Category
Drugs and Biologics
Product Code
58MCL09 RISANKIZUMAB-RZAA
Charges
75